At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 127 enrolled
Drug / intervention
Product A +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Multi-Center Clinical Trial to Evaluate the Efficacy of Two Acne Treatments
In Brief
A Phase 4 clinical trial evaluating Product A and Product B for Acne. Completed, enrolled 127 participants across 1 site.
Detailed Summary
The purpose of this study is to evaluate the efficacy of 2 acne treatments for 24 weeks of use in adult men and women with mild to moderate facial acne, at least 5 inflammatory lesions, and at least 10 - 100 non-inflammatory lesions.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAcne
CountriesUnited States
Collaborators--
Timeline
Phase 4CompletedFinished
2017201820192020202120222023202420252026
First PostedApr 2016
Enrollment StartMay 2016
Primary CompletionApr 2017
TodayJul 2026
First PostedApr 29, 2016
Enrollment StartMay 1, 2016
Primary CompletionApr 4, 2017
TodayJul 2, 2026
Enrollment to primary: 11 monthsPosted 10.2 years ago
Interventions
Product Adrug
Product A applied topically to the entire face or other affected area of the skin once daily
Product Bdrug
Product B applied topically to affected area of the skin 1 to 3 times daily